论文部分内容阅读
缺血性脑卒中如得不到及时有效的治疗,将引起严重的神经功能缺损,增加患者的死亡率和致残率~〔1〕。重组组织型纤溶酶原激活剂(rt-PA)溶栓治疗是急性缺血性脑卒中超早期最为有效的治疗方案~〔2〕,可以有效挽救患者缺血半暗带,最大限度恢复局部脑组织梗死区域的血液供应,避免不可逆性损伤现象的发生~〔3,4〕。本研究分析老年急性缺血性脑卒中患者静脉溶栓治疗的有效性和安全性。1资料与方法1.1一般资料我院2012年1月至2014年3月接受rt-PA(爱
If ischemic stroke is not treated promptly and effectively, it will cause serious neurological deficits and increase the mortality and morbidity of patients [1]. Recombinant tissue plasminogen activator (rt-PA) thrombolytic therapy is the most effective treatment of acute ischemic stroke in the early stage of treatment [2], can effectively save the patient penumbra, the maximum recovery of the local Cerebral infarction area of the blood supply, to avoid the occurrence of irreversible damage [3,4]. This study analyzed the efficacy and safety of intravenous thrombolysis in elderly patients with acute ischemic stroke. 1 Materials and Methods 1.1 General Information Our hospital from January 2012 to March 2014 to accept rt-PA (love